Pharmaco - Press Releases

Date	Title	Company
31-Oct-2019	The Alliance for Regenerative Medicine Outlines Recommendations for Increasing the Number of European-Based ATMP Clinical Trials	Alliance for Regenerative Medicine
31-Oct-2019	Aenitis Technologies and the Direction Générale de l'Armement (DGA) sign a partnership to develop a new AMSC-S project with a 1,2 million euros budget	AENITIS TECHNOLOGIES
31-Oct-2019	Biophytis Files Protocol Amendment to Optimize the SARA-INT Phase 2b Clinical Trial for Sarcopenia	Biophytis SA
31-Oct-2019	Bulletin from Moberg Pharma’s AGM on October 30th , 2019	Moberg Pharma
31-Oct-2019	Harley Street clinics to offer new brain stimulation treatment for depression	Flow Neuroscience
31-Oct-2019	First NHS patient receives Chiesi’s advanced-therapy-medicinal product, Holoclar▼ for moderate-to-severe limbal stem cell deficiency (LSCD) caused by chemical or thermal eye burns	Chiesi UK
31-Oct-2019	Investigational Ebola Vaccine from Janssen and Bavarian Nordic to Support Outbreak Response in Democratic Republic of the Congo	Bavarian Nordic A/S
31-Oct-2019	Continued Expansion of gel-e's Consumer Products Label	gel-e, Inc.
31-Oct-2019	Epigenomics AG sets subscription price at EUR 1.11 per new share	Epigenomics AG
31-Oct-2019	MagForce AG Publishes Financial Results for the First Half of 2019 and Operative Highlights	MagForce AG
31-Oct-2019	Sobi Publishes Report for Third Quarter 2019	Swedish Orphan Biovitrum AB
31-Oct-2019	Veloxis Increases Outlook for 2019 Based on Continued Strong Performance	Veloxis Pharmaceuticals
31-Oct-2019	Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health	NEX China 2020
30-Oct-2019	USDA, EPA and FDA announce partnership with the Food Waste Reduction Alliance	U.S. Food and Drug Administration
30-Oct-2019	ProteoGenix Launches New Human and Rabbit Antibody Libraries to Speed Up the Discovery of Better Therapeutic and Analytical Antibodies	ProteoGenix
30-Oct-2019	Vetter Provides Greater Flexibility in Secondary Packaging Through Collaborative Work	B3C newswire
30-Oct-2019	MultiTEP Platform-Based Epitope Vaccine Targeting the Phosphatase Activating Domain (PAD) of Tau Shows Clear Therapeutic Efficacy in PS19 Mice	Capo Therapeutics, Inc
30-Oct-2019	Sanifit announces that the Phase 2b CaLIPSO trial of SNF472 met its primary endpoint in slowing the progression of cardiovascular calcification in patients on hemodialysis Top line data to be presented at 2019 Scientific Sessions of American Heart Association	Sanifit
30-Oct-2019	Dupixent® (dupilumab) now approved in European Union for severe chronic rhinosinusitis with nasal polyposis	Regeneron
30-Oct-2019	SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor	B3C newswire